Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Ornellas, S. Burburan, D. Xisto, M. Morales, P. Rocco (Rio de Janeiro, Brazil). Anti-inflammatory effects of sevoflurane anesthesia in an experimental model of chronic allergic asthma. Eur Respir J 2008; 32: Suppl. 52, 3659

Member's Comments

No comment yet.

Related content which might interest you: Corticosteroid effects on airway neuroplasticity in experimental models of asthma Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Anti-inflammatory and anti-asthmatic effects of resolvin E1 in a mouse model of allergic asthma Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma Source: International Congress 2018 – Basic pharmacology Year: 2018 Effect of oral procaterol on allergic inflammation examined by a murine asthmatic model Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003 Neutraligands of CXCL12: Anti-inflammatory activity in an allergic model of asthma Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 The effects of capsaicin on airway inflammation in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 586s Year: 2004 Inhaled corticosteroids attenuate experimental allergic rhinitis related cough in guinea pigs Source: Eur Respir J 2006; 28: Suppl. 50, 220s Year: 2006 Effects of corticosteroid and montelukast treatment in inflammation in guinea pigs with chronic allergic inflammation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Characterisation of a chronic pre-clinical model of allergic asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Protective effect of inhaled glucocorticosteroids on COPD model. Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Bronchodilator effect of deep inhalation, airway inflammation, and allergen avoidance in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 383s Year: 2003 Effects of corticosteroids on airway inflammation in cough variant asthma Source: Annual Congress 2004 - Understanding airway regulation by airway monitoring Year: 2004 Antitussive and antiinflammatory effect of montelukast in patients with cough variant asthma Source: Eur Respir J 2006; 28: Suppl. 50, 440s Year: 2006 Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Does treatment of allergic rhinitis with intranasal steroids improve asthma control Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model Source: Eur Respir J 2004; 24: Suppl. 48, 351s Year: 2004